A Former Meta AI Leader Just Raised $9.3M to Replace Your EHR

Sunita Mohanty spent years building AI products at Meta, including the AI systems behind Ray-Ban smart glasses and Oculus. Now she’s pointing that experience at a different problem: the software DPC doctors use every day.

Her company, Ultralight, just raised $9.3 million to build what it calls an “AI-native operating system” for modern medical practices. The round was led by The General Partnership, with participation from Wisdom Ventures, Anthemis Group, Emerson Collective, and GSBackers. Former U.S. Surgeon General Vivek Murthy joined as an angel investor.

If you run a DPC practice, this one is worth paying attention to.

What Ultralight Actually Does

Ultralight, formerly known as Vibrant Practice, is an EHR platform designed from scratch for subscription-based, cash-pay practices. That includes DPC, concierge, functional medicine, and longevity clinics. The company’s pitch is straightforward: legacy EHRs were built for fee-for-service billing, and running a modern membership practice on that infrastructure creates unnecessary friction.

The platform bundles clinical documentation, telehealth, a patient portal, and AI-powered tools into a single system. Its AI scribe handles pre- and post-visit documentation. The company claims its automation saves providers 10 to 15 clinical hours per week and enables practices to see 25% more patients.

Dr. Philip Deibel of D5 Health, one of Ultralight’s early users, put it simply: “I don’t take a single note in one to two-hour visits. I save hours in my week.”

Crystal Brust, a PA-C at Farm to Functional, said tasks that used to take her 10 hours per week “are now done in 30 minutes.”

The Hint Health Connection

Here’s the detail that matters most for DPC practices: Ultralight has partnered with Hint Health. That positions Ultralight as the clinical layer in a stack where Hint handles the membership billing side.

If you’re a DPC doctor currently running the common Hint-plus-Elation combination, Ultralight is making a direct play for the Elation half of that equation. It’s not asking you to rip out your billing infrastructure. It’s saying the clinical side can be smarter.

That’s a calculated move. Many DPC practices have committed to Hint for billing and aren’t looking to switch. By integrating rather than competing with Hint, Ultralight avoids forcing an all-or-nothing decision.

Why This Funding Round Stands Out

DPC-specific tech doesn’t attract this kind of money very often. The $9.3 million round is notable for three reasons.

The investor list signals credibility. Emerson Collective, the organization founded by Laurene Powell Jobs, doesn’t typically invest in niche healthcare IT. Former Surgeon General Murthy lending his name adds a layer of public health legitimacy that most EHR startups can’t claim.

The AI-native framing is deliberate. Every EHR vendor is bolting AI features onto existing platforms right now. Ultralight’s argument is that building AI into the foundation produces a different result than adding it as an afterthought. Whether that plays out in practice remains to be seen, but the pitch resonates with doctors who are tired of clunky add-ons.

The target market is expanding. Ultralight isn’t limiting itself to DPC. By targeting the broader cash-pay, concierge, and longevity market, it’s betting on a larger addressable market while still serving the needs of membership-based practices. That gives it more room to grow and more revenue to reinvest in the product.

What This Means

The DPC EHR market has been relatively stable for a while. Atlas.md and Elation have large installed bases. Hint Health owns the billing layer for many practices. Newer entrants like SigmaMD and Cerbo have carved out their own niches. A well-funded newcomer with serious AI talent and a strategic Hint partnership adds a new option to that landscape.

For physicians evaluating their tech stack, this is worth watching but not worth rushing into. The claims are impressive, but Ultralight’s current user base is concentrated in functional medicine and longevity clinics, not traditional DPC practices. How well those features translate to a 600-patient primary care panel is an open question.

For the DPC industry more broadly, this round is a positive signal. Investors putting nearly $10 million into software built for subscription-based medicine suggests the market is big enough to attract real capital. That benefits everyone in the space, regardless of which platform you use.